Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Common Stock, par value $0.00001 per share | 36.1k | $17.01 | $614k | | 03/30/2023 |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 56.7k | $0.00 | $0 | | 03/30/2023 |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 30.8k | $17.57 | $541.1k | | 03/30/2023 |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 23.1k | $8.52 | $196.8k | | 03/30/2023 |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 10k | $7.69 | $76.9k | | 03/30/2023 |
03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 3k | $6.47 | $19.4k | | 03/30/2023 |
03/29/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 41.2k | $16.00 | $659.9k | | 03/28/2023 |
03/29/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 15k | $9.13 | $137k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 196.6k | $15.00 | $2.9M | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 15k | $2.15 | $32.2k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 4.9k | $1.88 | $9.2k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 15k | $1.26 | $18.9k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 53.1k | $1.23 | $65.3k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 15k | $1.08 | $16.2k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 10k | $1.04 | $10.4k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 24.5k | $4.65 | $113.9k | | 03/28/2023 |
03/28/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (right to buy) | 30k | $4.37 | $131.1k | | 03/28/2023 |
01/04/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 14k | $8.42 | $117.8k | | 12/30/2022 |
01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 204k | $8.52 | $1.7M | | 12/30/2022 |
01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 90.7k | $0.00 | $0 | | 12/30/2022 |
01/03/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 18.9k | $8.52 | $160.6k | | 12/30/2022 |
12/30/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 23.5k | $0.00 | $0 | | 12/30/2022 |
12/30/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 12.8k | $9.40 | $120.1k | | 12/30/2022 |
01/15/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 827 | $4.24 | $3.5k | | 01/15/2022 |
01/04/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 11.8k | $4.62 | $54.7k | | 01/03/2022 |
01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 174k | $4.88 | $849.1k | | 01/03/2022 |
01/03/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 3.9k | $4.88 | $19.1k | | 01/03/2022 |
01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 77.3k | $0.00 | $0 | | 01/03/2022 |
09/28/2021 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 6.7k | $0.00 | $0 | | 09/28/2021 |
09/28/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 2.8k | $6.50 | $18.5k | | 09/28/2021 |
01/19/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 994 | $6.68 | $6.6k | | 01/15/2021 |
01/15/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 686 | $6.48 | $4.4k | | 01/15/2021 |